Mariana de Souza Gomes, Founder and CEO“Access does not happen because a medicine exists. It happens when every legal, regulatory, financial and logistical step is shaped into a route the institution can trust,” says Mariana de Souza Gomes, Founder and CEO.
That philosophy shapes how Medssey handles each demand. Nothing begins without a medical prescription. The team identifies the molecule, presentation, posology and treatment duration before checking regulatory status, origin, supplier documentation, treatment quantity, storage needs, funding source, customs regime and tax treatment. Only after the route is settled does Medssey price the operation and commit to a deadline.
Structuring the Route Before the Shipment
Personal-use imports follow RDC 81/2008, while imports on behalf and order of an institution follow RDC 939/2024 and require the purchaser to hold the applicable regularization. Foreign exchange must also comply with Central Bank Resolution 277/2022. Medssey holds Anvisa authorization for imports on behalf and order of third parties.
Medssey maps these requirements first, then coordinates sourcing, Anvisa filings, customs, payment and delivery through one point of accountability. It buys from wholesalers and exporters and requires batch and expiry information, storage conditions and Certificates of Analysis as provided where available.
-
Access does not happen because a medicine exists. It happens when every legal, regulatory, financial and logistical step is shaped into a route the institution can trust.
For personal-use imports, the proforma invoice is used only for payment settlement. The commercial invoice and air waybill travel in the patient’s name, with Medssey preparing the models and aligning them with the supplier and courier. This discipline helps prevent shipments from being held, returned or seized, delays that can cost patients weeks of treatment.
Control Through Every Stage
Cold-chain planning begins before packing. Medssey confirms the required temperature range, qualified packaging and phase-change material and requires a data logger inside the shipment. It uses its own DHL, UPS and FedEx medical express accounts, then appoints the customs broker and contracted transport company for collection after clearance. If storage is needed before delivery, the medicine goes to a licensed facility with an appointed pharmacist.
Each operation is kept in a single dossier covering medical, regulatory, foreign exchange, customs and tax records. Clients receive updates across eight defined stages, each showing the Anvisa filing number, air waybill, tracking link and delivery forecast. Publicly funded and institutional operations close with a full accounting report that reconciles costs with the amount received.
That structure proved critical in a 2026 case involving a Brazilian municipal health authority. A court-ordered ophthalmic medicine purchase had stalled because responsibility for importing, overseas payment and expenditure accounting was unclear. Medssey restructured the operation with the municipality as the paying source and a designated public servant responsible for execution.
It sourced the medicine in Germany, handled foreign exchange, filed with Anvisa and answered sanitary requirements, including a custody term identifying the licensed municipal facility. The delivery was completed at the municipal warehouse against a signed pharmacist receipt, with cost reporting to the Health Secretariat.
Predictability Beyond the Transaction
Clients sometimes approach Medssey after being told an import is impossible or after a bank refuses payment. They value that the company defines the structure and executes it end-to-end rather than leaving them to coordinate suppliers, brokers, carriers and banks. They also value a 15-to-20-business-day window in most operations, cost transparency and knowing where the process stands.
With its headquarters in São Paulo and Rio de Janeiro, Medssey serves clients across every region of Brazil and is preparing to expand its institutional work alongside individual patient needs. By combining legal structure, documentation, sourcing and controlled delivery, it has earned recognition as Top Pharmaceutical Drug Import Solutions in Latin America 2026 while helping medicines reach patients through routes built for regulatory, customs, and public-accountability scrutiny.
Pharmaceutical Import Providers Must Establish the Legal Route
A hospital may locate a prescribed medicine abroad yet remain unable to purchase it. In Brazil, drugs lacking local registration or facing shortages can require different import arrangements depending on who is legally authorized to import and who will pay. Patient-directed orders and institutional procurement follow distinct rules. An incorrectly structured transaction can stall before customs clearance, regardless of supplier readiness. Before accepting a proposed delivery date, executives need to know whether a provider can establish a lawful import and payment structure.
Regulatory routes shape the paperwork each participant can issue and the payment a bank will process. Personal-use imports in Brazil follow RDC 81/2008, while RDC 939/2024 sets operating authorization requirements for companies importing on behalf of third parties. The purchaser’s own regulatory status must also be checked. Foreign exchange introduces separate banking requirements. A provider that treats these decisions as clerical work after sourcing may leave a hospital with a prescription but no executable purchase. Contract terms must distinguish who holds regulatory responsibility from who coordinates the filings.
Product availability alone does not establish a dependable supply channel. Institutions purchasing high-cost medicines need evidence of provenance that can withstand receipt checks and later review. Batch and expiration details must be traceable to certificates of analysis and origin issued at source. The supplier must also produce documentation acceptable to the importing country. A commercial invoice made out to the wrong party can delay an otherwise legitimate shipment. Buyers should establish who prepares shipping documents and who verifies consistency with the selected import arrangement.
Temperature-sensitive therapies expose weaknesses between overseas dispatch and local receipt. Qualified packaging must maintain the required range, while a data logger captures conditions during transit. An acceptable reading at delivery does not replace the recorded excursion history. Sanitary inspections or customs holds can extend the interval before release, increasing pressure on the transfer into licensed storage when needed. A provider's contract should specify responsibility for courier coordination, customs brokerage, airport collection and custody records. A fast shipping estimate offers little assurance if ownership becomes unclear at handoff.
“Medssey maintains a dossier for each operation and issues staged updates supported by filing and shipment references.”
Court-ordered purchases impose a separate accounting burden. An institution may need to reconcile overseas settlement with the amount advanced, retaining customs and tax records for subsequent review. Status reports also affect staff time. An Anvisa filing number, air waybill, tracking link and revised delivery forecast allow buyers to distinguish a shipment awaiting regulatory release from one still moving internationally. Responsibility for exceptions should remain clear even when several outside providers participate. The closing record should reconcile expenditure rather than simply confirm delivery.
Medssey structures medicine imports around the legally authorized importer and the permitted payment route before committing to execution. It starts from the prescription to verify the medicine's presentation and treatment duration, then checks supplier records and prepares documents for the applicable route. Its coordination covers foreign exchange, Anvisa filings, customs clearance and temperature-controlled transport with shipment data loggers when required. Medssey maintains a dossier for each operation and issues staged updates supported by filing and shipment references. For institutional and publicly funded transactions, it reconciles expenses against funds received. This service model addresses Brazilian hospitals and public health agencies procuring prescribed medicines under court orders, where the payer and legal importer must be identified before shipment.
...Read more
Pharmaceutical Drug Import Solutions in Latin America Info
Q1
What Do Pharmaceutical Drug Import Solutions in Latin America Include?
Pharmaceutical Drug Import Solutions in Latin America cover the regulatory, financial and logistical steps involved in bringing medicines across borders. These services may include supplier coordination, import authorization, payment arrangements, customs documentation and delivery. The process becomes more complex when a medicine is not registered locally, faces a shortage or is available only in a formulation approved in another country. A clear import plan helps organizations and patients understand the requirements before a shipment begins.
Q2
How Does Medssey Organize Pharmaceutical Drug Import Solutions in Latin America?
Pharmaceutical Drug Import Solutions in Latin America also depend on a clear review at the start. Medssey begins each request with a medical prescription and checks the medicine, dosage, treatment period and quantity before planning the import. It holds authorization from Anvisa for imports on behalf and order of third parties. The company also reviews the supplier's documents, storage requirements, funding source, customs process and tax treatment before setting a price or delivery timeline. It then coordinates sourcing, regulatory filings, payment, customs and delivery through one point of contact.
Q3
Why Is Regulatory Planning Important When Importing Medicines?
Pharmaceutical Drug Import Solutions in Latin America must account for the rules that apply to each type of import. Requirements can differ between medicines brought in for personal use and those imported on behalf of an institution. Importers may need to confirm the applicable authorization, purchaser status, foreign-exchange process and supporting documents before arranging payment or shipment. Early checks can reduce the risk of customs holds, returned packages or delays that interrupt access to needed treatment.
Q4
How Do Cold-Chain and Documentation Controls Protect Medicine Shipments?
Temperature-sensitive medicines need suitable packaging and careful handling throughout transit. Pharmaceutical Drug Import Solutions in Latin America should account for the required temperature range, qualified packaging, phase-change materials and temperature monitoring. A data logger can help record conditions during transport. Complete records also matter. A shipment dossier can bring together medical, regulatory, foreign-exchange, customs and tax documents, making it easier to track responsibilities and review the movement of each order.
Q5
How Does Medssey Support Shipment Visibility and Delivery?
For Pharmaceutical Drug Import Solutions in Latin America, Medssey uses a single dossier for each operation and provides updates across eight defined stages. These updates include the Anvisa filing number, air waybill, tracking link and expected delivery date. For temperature-controlled shipments, it plans cold-chain requirements before packing and uses medical express accounts with DHL, UPS and FedEx. When medicines need storage before delivery, the company arranges a licensed facility with an appointed pharmacist. Most operations follow a 15-to-20-business-day window.
Q6
What Should Organizations Consider When Choosing an Import Partner?
Pharmaceutical Drug Import Solutions in Latin America require more than access to overseas suppliers. Organizations should assess whether an import partner can explain the legal route, confirm the responsibilities of the purchaser, manage foreign payments and prepare complete customs records. It is also useful to understand how the provider monitors storage and transport, shares progress updates and accounts for costs. These checks help establish whether the import process is clear, traceable and suited to the medicine's requirements.
